AU Patent

AU2004299138B2 — Chemically Modified Small Molecules

Assigned to Nektar Therapeutics · Expires 2010-03-25 · 16y expired

What this patent protects

Patent listed against naloxegol-oxalate.

Drugs covered by this patent

Patent Metadata

Patent number
AU2004299138B2
Jurisdiction
AU
Classification
—
Expires
2010-03-25
Drug substance claim
No
Drug product claim
No
Assignee
Nektar Therapeutics
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.